These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11507232)

  • 1. Peptides corresponding to the heptad repeat motifs in the transmembrane protein (gp41) of human immunodeficiency virus type 1 elicit antibodies to receptor-activated conformations of the envelope glycoprotein.
    de Rosny E; Vassell R; Wingfield PT; Wild CT; Weiss CD
    J Virol; 2001 Sep; 75(18):8859-63. PubMed ID: 11507232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41.
    Gorny MK; Zolla-Pazner S
    J Virol; 2000 Jul; 74(13):6186-92. PubMed ID: 10846104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligomer-specific conformations of the human immunodeficiency virus (HIV-1) gp41 envelope glycoprotein ectodomain recognized by human monoclonal antibodies.
    Yuan W; Li X; Kasterka M; Gorny MK; Zolla-Pazner S; Sodroski J
    AIDS Res Hum Retroviruses; 2009 Mar; 25(3):319-28. PubMed ID: 19292593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates.
    Golding H; Zaitseva M; de Rosny E; King LR; Manischewitz J; Sidorov I; Gorny MK; Zolla-Pazner S; Dimitrov DS; Weiss CD
    J Virol; 2002 Jul; 76(13):6780-90. PubMed ID: 12050391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of HIV-1 gp41-directed neutralizing and non-neutralizing fragment antibody binding domain (Fab) and single chain variable fragment (ScFv) antibodies to the ectodomain of gp41 in the pre-hairpin and six-helix bundle conformations.
    Louis JM; Aniana A; Lohith K; Sayer JM; Roche J; Bewley CA; Clore GM
    PLoS One; 2014; 9(8):e104683. PubMed ID: 25105806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conformation-specific monoclonal antibody reacting with fusion-active gp41 from the human immunodeficiency virus type 1 envelope glycoprotein.
    Jiang S; Lin K; Lu M
    J Virol; 1998 Dec; 72(12):10213-7. PubMed ID: 9811763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
    Finnegan CM; Berg W; Lewis GK; DeVico AL
    J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-helix bundle completion in the distal C-terminal heptad repeat region of gp41 is required for efficient human immunodeficiency virus type 1 infection.
    Liu D; Wang H; Yamamoto M; Song J; Zhang R; Du Q; Kawaguchi Y; Inoue JI; Matsuda Z
    Retrovirology; 2018 Apr; 15(1):27. PubMed ID: 29609648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein.
    Edwards TG; Wyss S; Reeves JD; Zolla-Pazner S; Hoxie JA; Doms RW; Baribaud F
    J Virol; 2002 Mar; 76(6):2683-91. PubMed ID: 11861835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein.
    Earl PL; Broder CC; Doms RW; Moss B
    J Virol; 1997 Apr; 71(4):2674-84. PubMed ID: 9060620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure.
    Banerjee S; Shi H; Habte HH; Qin Y; Cho MW
    Virology; 2016 Mar; 490():17-26. PubMed ID: 26803471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.
    Pacheco B; Alsahafi N; Debbeche O; Prévost J; Ding S; Chapleau JP; Herschhorn A; Madani N; Princiotto A; Melillo B; Gu C; Zeng X; Mao Y; Smith AB; Sodroski J; Finzi A
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28003492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: implications for fusion-inducing conformational changes.
    de Rosny E; Vassell R; Jiang S; Kunert R; Weiss CD
    J Virol; 2004 Mar; 78(5):2627-31. PubMed ID: 14963170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternative conformation of the gp41 heptad repeat 1 region coiled coil exists in the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor.
    Mische CC; Yuan W; Strack B; Craig S; Farzan M; Sodroski J
    Virology; 2005 Jul; 338(1):133-43. PubMed ID: 15950253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
    Marin MH; Peña LP; Tanty CR; Higginson Clarke D; Arenas MA; Noguerol KR; León CS
    Prep Biochem Biotechnol; 2004 Aug; 34(3):227-37. PubMed ID: 15461139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex.
    Park EJ; Gorny MK; Zolla-Pazner S; Quinnan GV
    J Virol; 2000 May; 74(9):4183-91. PubMed ID: 10756031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope.
    Ofek G; Tang M; Sambor A; Katinger H; Mascola JR; Wyatt R; Kwong PD
    J Virol; 2004 Oct; 78(19):10724-37. PubMed ID: 15367639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions.
    Neurath AR; Strick N; Lin K; Jiang S
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):687-96. PubMed ID: 7576928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quaternary protein mimetics of gp41 elicit neutralizing antibodies against HIV fusion-active intermediate state.
    Sadler K; Zhang Y; Xu J; Yu Q; Tam JP
    Biopolymers; 2008; 90(3):320-9. PubMed ID: 18338371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody.
    Jiang S; Lin K; Zhang L; Debnath AK
    J Virol Methods; 1999 Jun; 80(1):85-96. PubMed ID: 10403680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.